We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$320M
AUM Growth
-$146M
Cap. Flow
-$159M
Cap. Flow %
-49.86%
Top 10 Hldgs %
67.17%
Holding
109
New
50
Increased
6
Reduced
14
Closed
21

Sector Composition

Rank Sector Weight
1 Financials 9.95%
2 Energy 9.29%
3 Technology 6.39%
4 Materials 4.86%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMX
26
DELISTED
Terminix Global Holdings, Inc.
TMX
$1.88M 0.59%
74,650
CEF icon
27
Sprott Physical Gold and Silver Trust
CEF
$7.35B
$1.35M 0.42%
120,000
HIHO icon
28
Highway Holdings
HIHO
$5.04M
$1.27M 0.4%
+618,702
New +$2.33M
XXII
29
22nd Century Group
XXII
$1.36M
0
POT
30
DELISTED
Potash Corp Of Saskatchewan
POT
$1.18M 0.37%
65,000
NOVN
31
DELISTED
Novan, Inc. Common Stock
NOVN
$1.11M 0.35%
+4,099
New +$945K
QRVO icon
32
PUT
Qorvo
QRVO
$8.09B
$1.05M 0.33%
20,000
-24,800
-55% -$1.35M
SNOAW
33
DELISTED
Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
$1.02M 0.32%
+202,014
New +$74K
CASC
34
DELISTED
Cascadian Therapeutics, Inc.
CASC
$988K 0.31%
229,286
+123,003
+116% +$795K
ALDW
35
DELISTED
Alon USA Partners LP
ALDW
$960K 0.3%
+100,000
New +$897K
CMG icon
36
Chipotle Mexican Grill
CMG
$43B
$868K 0.27%
115,000
AUPH icon
37
Aurinia Pharmaceuticals
AUPH
$1.92B
$815K 0.25%
+388,008
New +$1.25M
IRD
38
Opus Genetics
IRD
$282M
$768K 0.24%
11,270
-7,834
-41% -$638K
NXTDW
39
DELISTED
Nxt-ID, Inc.
NXTDW
$742K 0.23%
269,900
AIM
40
AIM ImmunoTech
AIM
$6.54M
$739K 0.23%
244
-55
-18% -$222K
AFMD
41
DELISTED
Affimed
AFMD
$654K 0.2%
36,316
TPST icon
42
Tempest Therapeutics
TPST
$13.9M
$637K 0.2%
+142
New +$1.77M
ARWR icon
43
Arrowhead Research
ARWR
$12.1B
$548K 0.17%
+353,428
New +$1.51M
CVRR
44
DELISTED
CVR Refining, LP
CVRR
$520K 0.16%
+50,000
New +$437K
ALPN
45
DELISTED
Alpine Immune Sciences Inc
ALPN
$422K 0.13%
+47,072
New +$938K
ADAP
46
DELISTED
Adaptimmune Therapeutics
ADAP
$418K 0.13%
+103,282
New +$495K
CHMA
47
DELISTED
Chiasma, Inc. Common Stock
CHMA
$400K 0.13%
+205,380
New +$468K
VSTM icon
48
Verastem
VSTM
$547M
$386K 0.12%
+28,704
New +$427K
ADVM
49
DELISTED
Adverum Biotechnologies
ADVM
$373K 0.12%
+12,854
New +$420K
APOPW
50
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$350K 0.11%
+113,347
New +$83.9K

Similar funds

Anson Funds Management's Q4 2016 Portfolio in Review

As of Q4 2016, Anson Funds Management held 109 positions worth $320M, down 31% from $465M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Anson Funds Management withdrew a net $159M in Q4 2016, closing 21 positions and reducing 14 holdings. Its most notable exit was Sprott Physical Gold, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 10% of assets, up from 9.7% a quarter earlier, followed by Energy and Technology.

Against the trend, Anson Funds Management opened a new position in Caterpillar worth $4.64M.

  • Anson Funds Management's largest Q4 2016 buy was Caterpillar: 50,000 shares worth $4.64M.
  • Anson Funds Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2016, an estimated $20.8M increase.
  • Anson Funds Management's biggest Q4 2016 reduction was Bank of America, cutting an estimated $26.8M.
  • Anson Funds Management fully exited Sprott Physical Gold in Q4 2016, selling an estimated $11.1M.
  • Anson Funds Management's ten largest holdings make up 67% of its $320M portfolio in Q4 2016.
  • Anson Funds Management opened 50 new positions and closed 21 in Q4 2016.
  • Anson Funds Management's portfolio value fell 31% quarter-over-quarter to $320M.

Based on Anson Funds Management's 13F filing for Q4 2016, filed 14 Feb 2017.